Stocks · Healthcare · Medical - Devices
Pacific Biosciences of California, Inc. PACB
$2.54 +1.20% Close, Oct 2, 2026 · NASDAQ · Market cap $788.9M
Strong trend
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -102.1% from -442.6% a year earlier.
- Over the past year the stock returned +84.1%, ahead of the S&P 500 by 69.0 percentage points.
- Revenue over the last four quarters was $159.3M, up 2.0% from a year earlier, slowing from 5.0% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 33%
- Revenue growth, 3-year CAGRBottom 43%
- Revenue growth accelerationBottom 32%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 48%
- Gross marginBottom 24%
- Operating marginBottom 28%
- Accruals (lower is better)Bottom 10%
- Interest coverBottom 17%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 37%
- Free-cash-flow yieldBottom 23%
- EBITDA / enterprise valueBottom 44%
- Sales / enterprise valueBottom 33%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 33%
- 6-month returnTop 11%
- 1-year return vs S&P 500Top 18%
- Distance from 52-week highTop 9%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 17%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 16%
- Upside to consensus price targetBottom 1%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 9%
- Maximum drawdown, 3 yearsBottom 13%
- Beta vs S&P 500 (lower is better)Top 34%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 5.0% | 2.0% | ↓ |
| Gross margin | 21.4% | 36.0% | ↑ |
| Operating margin | -442.6% | -102.1% | ↑ |
| FCF margin | -100.8% | -107.5% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 2.0% | 5.0% | ↓ | Bottom 33% |
| Gross margin | 36.0% | 21.4% | ↑ | Bottom 24% |
| Operating margin | -102.1% | -442.6% | ↑ | Bottom 28% |
| Net margin | -82.5% | -337.2% | ↑ | — |
| Free-cash-flow margin | -107.5% | -100.8% | ↓ | — |
| Return on invested capital | -23.7% | — | Bottom 48% | |
| Revenue growth, 3-year CAGR | 7.6% | — | Bottom 43% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 4.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 14.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -5.6 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -42.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.58%
- Shareholder yield
- -0.58%
- Share count change, 1 year
- +3.5%
- Share count change, 3-year CAGR
- +7.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +33.7%
- Average 2-day reaction, last 8
- -0.9%
- Positive 20 days after report
- 1 of 8
Analysts
- Consensus price target
- $1.18
- Target vs current price
- -53.5%
- Analysts with a rating
- 18
- Share rating Buy or Strong Buy
- 50%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 3, 2026 | -9.4% | +1.4% | -15.0% | +0.0% | — |
| May 7, 2026 | +82.4% | -3.5% | -25.7% | -4.7% | -17.0% |
| Feb 12, 2026 | +36.8% | +0.0% | -8.7% | -31.0% | -23.4% |
| Nov 5, 2025 | +25.0% | -4.0% | -7.0% | +21.5% | +3.0% |
| Aug 7, 2025 | +27.8% | -8.7% | -7.2% | -10.1% | +40.6% |
| May 8, 2025 | -657.9% | +6.2% | -2.7% | -11.5% | +23.0% |
| Feb 13, 2025 | +0.0% | +8.8% | +20.6% | -11.8% | -17.6% |
| Nov 7, 2024 | +0.0% | -7.5% | -25.3% | -25.3% | -38.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | -$0.14 | -$0.13 | -9.4% | $39.0M |
| May 7, 2026 | -$0.03 | -$0.17 | +82.4% | $37.2M |
| Feb 12, 2026 | -$0.12 | -$0.19 | +36.8% | $44.6M |
| Nov 5, 2025 | -$0.12 | -$0.16 | +25.0% | $38.4M |
| Aug 7, 2025 | -$0.13 | -$0.18 | +27.8% | $39.8M |
| May 8, 2025 | -$1.44 | -$0.19 | -657.9% | $37.2M |
| Feb 13, 2025 | -$0.20 | -$0.20 | +0.0% | $39.2M |
| Nov 7, 2024 | -$0.22 | -$0.22 | +0.0% | $40.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 9.00× | — | — | Bottom 33% |
| Free-cash-flow yield | -21.69% | — | — | Bottom 23% |
| Earnings yield | -16.93% | — | — | Bottom 37% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 12
- Days above the 200-day average
- 7
- 50-day average slope (20 days)
- +1.1%
- 200-day average slope (20 days)
- -3.9%
- Distance from 50-day average
- +78.6%
- Distance from 200-day average
- +61.3%
- RSI (14)
- 86.5
- Relative volume
- 2.10×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 97.2%
- Volatility vs own 5-year history
- 64th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.86
- Correlation with S&P 500
- 0.13
- Current drawdown from 1-year high
- -4.9%
- Maximum drawdown, 3 years
- -91.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 11, 2021 | May 27, 2025 | -98.2% | 1076 days | Not yet recovered |
| Jan 19, 2021 | Jan 27, 2021 | -22.7% | 6 days | 10 days (Feb 10, 2021) |
| Oct 19, 2020 | Nov 4, 2020 | -17.1% | 12 days | 5 days (Nov 11, 2020) |
| Nov 13, 2020 | Nov 24, 2020 | -13.9% | 7 days | 4 days (Dec 1, 2020) |
| Dec 8, 2020 | Dec 17, 2020 | -11.2% | 7 days | 2 days (Dec 21, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $788.9M
- EPS, diluted (TTM)
- -$0.43
- Revenue (TTM)
- $159.3M
- 52-week range
- $1.07 – $2.73
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $130.5M | $128.3M | $200.5M | $154.0M | $160.0M |
| Gross profit | $58.9M | $49.0M | $52.8M | $37.3M | $50.7M |
| Operating income | -$210.4M | -$307.2M | -$334.5M | -$474.3M | -$557.6M |
| Net income | -$181.2M | -$314.2M | -$306.7M | -$309.9M | -$546.4M |
| EPS (diluted) | -$0.89 | -$1.40 | -$1.21 | -$1.07 | -$1.82 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $40.0M | $39.2M | $37.2M | $39.8M | $38.4M | $44.6M | $37.2M | $39.0M |
| Net income | -$60.7M | $2.4M | -$426.1M | -$41.9M | -$38.0M | -$40.4M | -$8.3M | -$44.7M |
| EPS (diluted) | -$0.22 | $0.01 | -$1.44 | -$0.14 | -$0.13 | -$0.13 | -$0.03 | -$0.14 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$111.2M | -$263.2M | -$266.5M | -$206.1M | -$111.2M |
| Capital expenditure | -$5.9M | -$16.9M | -$8.8M | -$6.2M | -$2.7M |
| Free cash flow | -$117.1M | -$280.1M | -$275.4M | -$212.2M | -$113.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $294.8M | $11.2M | $204.5M | $7.7M | $3.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $236.9M
- Total assets
- $751.9M
- Total liabilities
- $785.1M
- Total debt
- $706.1M
- Net debt
- $645.1M
- Shareholders’ equity
- -$33.2M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 48,892,225
- Days to cover
- 10.49
- Change vs previous report
- -1.4%
FINRA short interest, settlement date Sep 15, 2026.